SBIA
VIVO

Sheaff Brock Investment Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,454
Closed -$1.09M – 546
2021
Q1 		$1.09M Buy
+41,454
New +$986K 0.09% 148

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sheaff Brock Investment Advisors's VIVO Position: Q2 2021 in Review

Sheaff Brock Investment Advisors sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 41,454 shares — an estimated $1.09M sold.

Sheaff Brock Investment Advisors first reported a position in VIVO in Q1 2021 and held it in 1 quarter. The position peaked at $1.09M in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Sheaff Brock Investment Advisors reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 41,454 Meridian Bioscience Inc shares in Q2 2021, an estimated $1.09M.
  • Sheaff Brock Investment Advisors first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's Meridian Bioscience Inc position peaked at $1.09M in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.